Bolt Biotherapeutics (BOLT) Short Interest Ratio & Short Volume → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free BOLT Stock Alerts $0.79 -0.03 (-3.65%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media Bolt Biotherapeutics Short Interest DataCurrent Short Volume2,120,000 sharesPrevious Short Volume2,080,000 sharesChange Vs. Previous Month+1.92%Dollar Volume Sold Short$2.34 millionShort Interest Ratio / Days to Cover16.8Last Record DateApril 30, 2024Outstanding Shares38,128,000 sharesFloat Size24,090,000 sharesShort Percent of Float8.80%Today's Trading Volume598,021 sharesAverage Trading Volume310,959 sharesToday's Volume Vs. Average192% Short Selling Bolt Biotherapeutics ? Sign up to receive the latest short interest report for Bolt Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBOLT Short Interest Over TimeBOLT Days to Cover Over TimeBOLT Percentage of Float Shorted Over Time Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Bolt Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,120,000 shares $2.34 million +1.9%8.8%16.8 $1.11 4/15/20242,080,000 shares $2.35 million +5.6%8.6%16.2 $1.13 3/31/20241,970,000 shares $2.76 million +0.5%8.2%16.3 $1.40 3/15/20241,960,000 shares $2.18 million +12.6%8.2%15.6 $1.11 2/29/20241,740,000 shares $1.98 million +7.4%7.3%13.7 $1.14 2/15/20241,620,000 shares $1.83 million No Change6.8%13.6 $1.13 Get the Latest News and Ratings for BOLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,620,000 shares $1.64 million -1.2%6.8%15.1 $1.01 1/15/20241,640,000 shares $1.89 million No Change6.7%15.9 $1.15 12/31/20231,640,000 shares $1.84 million -0.6%6.7%15.5 $1.12 12/15/20231,650,000 shares $1.77 million +0.6%6.7%12.2 $1.07 11/30/20231,640,000 shares $1.40 million No Change6.7%13.9 $0.85 11/15/20231,640,000 shares $1.61 million +2.5%6.7%14.6 $0.98 10/31/20231,600,000 shares $1.57 million -3.0%6.6%14.6 $0.98 10/15/20231,650,000 shares $1.58 million +5.8%7.0%14.2 $0.96 9/30/20231,560,000 shares $1.62 million +0.7%6.6%13.8 $1.04 9/15/20231,550,000 shares $1.69 million +3.3%6.6%20.1 $1.09 8/31/20231,500,000 shares $1.65 million -12.3%6.4%16.1 $1.10 8/15/20231,710,000 shares $2.12 million +3.6%7.3%16.4 $1.24 7/31/20231,650,000 shares $2.23 million +5.8%7.0%12.3 $1.35 7/15/20231,560,000 shares $2.12 million +0.7%6.7%10.7 $1.36 6/30/20231,550,000 shares $1.98 million No Change6.6%9.6 $1.28 6/15/20231,550,000 shares $2.34 million +2.0%6.6%7 $1.51 5/31/20231,520,000 shares $2.61 million +1.3%6.5%6.8 $1.72 5/15/20231,500,000 shares $2.93 million No Change6.4%6.3 $1.95 4/30/20231,500,000 shares $2.37 million +0.7%6.2%6 $1.58 4/15/20231,490,000 shares $2.18 million -4.5%6.2%5.9 $1.46 3/31/20231,560,000 shares $2.17 million +4.0%6.5%6.3 $1.39 3/15/20231,500,000 shares $2.19 million No Change6.2%5.3 $1.46 2/28/20231,500,000 shares $2.42 million -11.8%6.2%5.2 $1.61 2/15/20231,700,000 shares $2.38 million +0.6%7.1%5.8 $1.40 1/31/20231,690,000 shares $2.48 million +0.6%7.0%5.8 $1.47 1/15/20231,680,000 shares $2.52 million -3.5%7.0%6 $1.50 12/30/20221,740,000 shares $2.26 million -1.1%7.2%6.6 $1.30 12/15/20221,760,000 shares $2.32 million -1.7%8.6%10.1 $1.32 11/30/20221,790,000 shares $2.65 million +9.2%8.8%11 $1.48 11/15/20221,640,000 shares $2.10 million +43.9%8.1%11.9 $1.28 10/31/20221,140,000 shares $1.58 million +3.6%5.4%10.3 $1.39 10/15/20221,100,000 shares $1.54 million -1.8%5.2%10 $1.40 9/30/20221,120,000 shares $1.66 million +18.1%5.3%8.9 $1.48 9/15/2022948,500 shares $1.72 million +29.2%4.5%4.9 $1.81Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… BOLT Short Interest - Frequently Asked Questions What is Bolt Biotherapeutics' current short interest? Short interest is the volume of Bolt Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,120,000 shares of BOLT short. 8.80% of Bolt Biotherapeutics' shares are currently sold short. Learn More on Bolt Biotherapeutics' current short interest. What is a good short interest ratio for Bolt Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BOLT shares currently have a short interest ratio of 17.0. Learn More on Bolt Biotherapeutics's short interest ratio. What is a good short interest percentage for Bolt Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.80% of Bolt Biotherapeutics' floating shares are currently sold short. Is Bolt Biotherapeutics' short interest increasing or decreasing? Bolt Biotherapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,120,000 shares, an increase of 1.9% from the previous total of 2,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bolt Biotherapeutics' float size? Bolt Biotherapeutics currently has issued a total of 38,128,000 shares. Some of Bolt Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bolt Biotherapeutics currently has a public float of 24,090,000 shares. How does Bolt Biotherapeutics' short interest compare to its competitors? 8.80% of Bolt Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bolt Biotherapeutics: Fortress Biotech, Inc. (12.69%), Regulus Therapeutics Inc. (7.33%), Rigel Pharmaceuticals, Inc. (3.23%), Rockwell Medical, Inc. (2.13%), Reviva Pharmaceuticals Holdings, Inc. (4.48%), Clene Inc. (0.53%), BioLineRx Ltd. (0.51%), Immuneering Co. (15.37%), Reneo Pharmaceuticals, Inc. (13.80%), Equillium, Inc. (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bolt Biotherapeutics stock? Short selling BOLT is an investing strategy that aims to generate trading profit from Bolt Biotherapeutics as its price is falling. BOLT shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bolt Biotherapeutics? A short squeeze for Bolt Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BOLT, which in turn drives the price of the stock up even further. How often is Bolt Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOLT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Fortress Biotech Short Interest Regulus Therapeutics Short Interest Rigel Pharmaceuticals Short Interest Rockwell Medical Short Interest Reviva Pharmaceuticals Short Interest Clene Short Interest BioLineRx Short Interest Immuneering Short Interest Reneo Pharmaceuticals Short Interest Equillium Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BOLT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings